TICKERNERD
Menu
CAHCAHHealthcare · Medical Distribution

CAH Stock Forecast: Cardinal Health, Inc. Price Predictions for 2026-2027

Last close, 5 Nov 2026
$268
+2.25% on the day

The 17 Wall Street analysts covering Cardinal Health, Inc. hold a median 12-month price target of $277 — +3.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 98 of 100 as at 5 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$62.0B
Ticker Nerd rank
98/ 100
Median analyst target
$277
Analysts covering
17
Revenue$63.7B+5.8% y/y
Operating income$814.0M
Net income$400.0M
Free cash flow$1.4B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+6.7%
1M
+14.9%
YTD
+31.6%
1Y
+37.4%
From 52W high
0.0%
From 52W low
+47.4%
$182
$268
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CAH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Cardinal Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 5 Nov 2026
98/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
99
Momentum
97
Value
89
Issuance
88
Quality
87
Revisions
76
Accruals
74
Growth
68
Size
4

Volatility (99): The share price has been relatively steady.

Growth (68): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CAH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CAH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$180$200$220$240$260$280$300Jan 26Apr 26Jul 26Oct 26CAHHigh $295Median $277Low $235

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says17 analysts
14 Buy3 Hold0 Sell
Low $235Median $277High $295

The green dot is the last close — the median target sits +3.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 9 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
30 Oct 2026Morgan StanleyMaintainsOverweight$265 → $286
20 Oct 2026MizuhoMaintainsOutperform—
20 Oct 2026MizuhoMaintainsOutperform$250 → $280
16 Oct 2026UBSMaintainsBuy—
16 Oct 2026UBSMaintainsBuy$280 → $295
19 Aug 2026RBC CapitalInitiatesOutperform—
19 Aug 2026RBC CapitalInitiatesOutperform$276
13 Aug 2026BarclaysMaintainsOverweight$258 → $275
13 Aug 2026BarclaysMaintainsOverweight—
13 Aug 2026JP MorganMaintainsNeutral$215 → $260
13 Aug 2026JP MorganMaintainsNeutral—
13 Aug 2026TD CowenMaintainsBuy$275 → $280
13 Aug 2026TD CowenMaintainsBuy—
12 Aug 2026BairdMaintainsOutperform—
12 Aug 2026BairdMaintainsOutperform$251 → $274
12 Aug 2026CitigroupMaintainsBuy$265 → $280
12 Aug 2026CitigroupMaintainsBuy—
12 Aug 2026Evercore ISI GroupMaintainsOutperform$265 → $270
12 Aug 2026Evercore ISI GroupMaintainsOutperform—
12 Aug 2026MizuhoMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CAH appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF

  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CAH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 5 Nov 2026, Cardinal Health, Inc. returned +37.4% against +9.3% for the S&P 500, dividends included.

CAH vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140Jan 26Apr 26Jul 26Oct 26CAHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CAH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
+4.0%
Analysts raising
0
Analysts cutting
1
Fundamentals

Cardinal Health, Inc. (CAH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
37.0×

Cheaper than 19% of US stocks

Price / sales
0.2×

Cheaper than 90% of US stocks

Price / book
−23.0×

Cheaper than 98% of US stocks

EV / EBITDA
15.6×

Cheaper than 22% of US stocks

Growth & margins
Revenue growth (YoY)
5.8%

Higher than 42% of US stocks

Earnings growth (YoY)
66.5%

Higher than 79% of US stocks

Gross margin
4.0%

Higher than 6% of US stocks

Operating margin
1.3%

Higher than 47% of US stocks

Net margin
0.7%

Higher than 48% of US stocks

Returns & dividend
Return on equity
−62.9%

Higher than 18% of US stocks

Return on assets
3.7%

Higher than 69% of US stocks

Dividend yield
0.8%

Higher than 68% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Cardinal Health, Inc. (CAH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Cardinal Health, Inc. has a market value of $62.0B and an enterprise value of $66.2B.

  • Revenue in the twelve months to 30 June 2026: $254.2B. The latest quarter grew 5.8% year on year.

  • Net income over the same four quarters: $1.7B, a 0.7% net margin.

  • Diluted earnings per share, trailing twelve months: $7.24.

  • Free cash flow in the twelve months to 30 June 2026: $4.5B.

  • Cardinal Health, Inc. spent $1.4B on share buybacks and $491.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 233.0M.

  • Trailing P/E: 37.0×; forward P/E: 19.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.77%, paying out 28% of earnings.

  • Cardinal Health, Inc. employs 58,788 people — $4.3M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 6 Nov 2026

Data provided by Twelve Data

Peers

CAH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Distribution
CompanyMarket capTKN rank
CAHCardinal Health, Inc.$62.0B98
CORCencora, Inc.$64.8B77
MCKMcKesson Corp.$125.5B93
HSICHenry Schein, Inc.$9.8B82
BDXBecton, Dickinson & Co.*$58.8B92
BSXBoston Scientific Corp.*$66.2B57
EWEdwards Lifesciences Corp.*$58.1B87

* Nearest Healthcare names by size — few medical distribution companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Cardinal Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CAH news & analysis

Cardinal Health, Inc. (CAH) Q1 2027 Earnings Call Transcript

Seeking Alpha · 5 Nov 2026neutral

Cardinal Health held its first-quarter fiscal 2027 earnings call on November 5, 2026, with CEO Jason Hollar, CFO Aaron Alt, and other company representatives participating. The excerpt lists call participants but provides no financial results or substantive discussion.

Why it matters — CAH watchers are alerted to the Q1 fiscal 2027 earnings call, but the excerpt does not provide details to assess the quarter.

CAH Q1 Earnings & Revenues Beat Estimates on Pharma Strength

Zacks Investment Research · 5 Nov 2026positive

Cardinal Health reported Q1 FY27 earnings and revenue above estimates, driven by pharmaceutical sales growth, and raised its full-year earnings outlook.

Why it matters — CAH watchers may note the better-than-estimated quarterly results and the higher full-year earnings outlook.

Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure

Benzinga · 5 Nov 2026positive

Cardinal Health shares rose Thursday after the company reported better-than-expected first-quarter fiscal 2027 earnings and updated its fiscal 2027 outlook.

Why it matters — The earnings result and revised outlook are relevant to CAH watchers assessing the company’s latest performance and expectations.

Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings

Benzinga · 5 Nov 2026positive

U.S. stocks traded lower Thursday, with the Nasdaq Composite falling around 4.5%. Cardinal Health shares gained after the company reported upbeat first-quarter earnings, according to the headline.

Why it matters — The item reports a gain in Cardinal Health shares following upbeat first-quarter earnings, despite a broader market decline.

Compared to Estimates, Cardinal (CAH) Q1 Earnings: A Look at Key Metrics

Zacks Investment Research · 5 Nov 2026neutral

The article focuses on how Cardinal Health’s key metrics for the quarter ended September 2026 compared with Wall Street estimates and year-ago values. The excerpt does not provide specific results.

Why it matters — These comparisons offer CAH watchers additional context on quarterly performance beyond the top- and bottom-line figures.

FAQ

Frequently asked questions about CAH stock

What is the CAH stock price forecast for 2026-2027?

The 17 Wall Street analysts covering Cardinal Health, Inc. have a median 12-month price target of $277, with estimates ranging from $235 to $295. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CAH stock a buy right now?

Of the 17 analysts covering Cardinal Health, Inc., 14 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Cardinal Health, Inc. 98 out of 100 across roughly 4,600 US stocks as at 5 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CAH?

As at 5 Nov 2026, Cardinal Health, Inc. ranks 98 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (99 of 100).

Will CAH stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +3.4% from the last close, and Ticker Nerd's factor model ranks Cardinal Health, Inc. 98 out of 100 as at 5 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CAH stock forecast for 2030?

No analyst covering Cardinal Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CAH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $235 to $295 over the next 12 months.

How has CAH stock performed over the past year?

Cardinal Health, Inc. returned +37.4% over the 12 months to 5 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Cardinal Health, Inc. do?

Cardinal Health, Inc. is a healthcare services and products company that supports the flow of medicines, medical supplies, and related solutions across the healthcare system.

What is the latest news on CAH?

The most recent item we track (Seeking Alpha, 5 Nov 2026): "Cardinal Health, Inc. (CAH) Q1 2027 Earnings Call Transcript". Cardinal Health held its first-quarter fiscal 2027 earnings call on November 5, 2026, with CEO Jason Hollar, CFO Aaron Alt, and other company representatives participating. The excerpt lists call participants but provides no financial results or substantive discussion.

Company

About Cardinal Health, Inc.

Cardinal Health, Inc. is a healthcare services and products company that supports the flow of medicines, medical supplies, and related solutions across the healthcare system. Cardinal Health distributes pharmaceuticals and specialty products, manufactures and distributes medical and laboratory products, and provides performance and data solutions for healthcare facilities. Its operations serve hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients at home. The company also supplies home-health and direct-to-patient products and services, along with nuclear pharmacy and manufacturing capabilities that support specialized healthcare needs. With a broad role in healthcare logistics and product distribution, Cardinal Health, Inc. helps connect manufacturers, providers, and patients through integrated offerings that span the care continuum.

CEO Mr. Jason M. Hollar · 58,788 employees · United States · https://www.cardinalhealth.com